Published in Blood Weekly, December 6th, 2001
Dr. Allen Eng-Juh Yeoh and colleagues at St. Jude Children's Research Hospital and the University of Tennessee in Memphis, the University of Nebraska in Omaha, and the National University of Singapore conducted a study comparing the "efficacy, toxicity, and cost of topotecan-filgrastim and filgrastim alone for mobilizing peripheral blood stem cells (PBSCs)" in children with brain and spinal tumors.
The topotecan-filgrastim combination was...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Blood Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.